Form 4: CEO Jack Bendheim Sells PAHC Shares via 10b5-1 Plan

Phibro Animal Health CEO Jack Bendheim and BFI Co., LLC sold a total of 14,080 Class A Common Stock shares in late March 2026 through a pre-arranged 10b5-1 trading plan.

Summary

• Jack Bendheim, President and CEO, Director, and 10% Owner of Phibro Animal Health Corp (PAHC), along with BFI Co., LLC (also a 10% owner), reported sales of Class A Common Stock.
• The sales were executed on March 30, 2026, and March 31, 2026.
• A total of 14,080 shares were sold by BFI Co., LLC.
• The sales were conducted under a Rule 10b5-1 trading plan adopted by BFI Co., LLC on December 11, 2025.
• Sale prices ranged from $53.23 to $54.51 per share, with weighted average prices reported for each transaction.
• Following these transactions, BFI Co., LLC indirectly holds 38,120 shares, and Jack Bendheim directly holds 16,840 shares.
• Jack Bendheim exercises voting and dispositive power over BFI Co., LLC and disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider selling can sometimes be a negative signal, the execution under a pre-arranged 10b5-1 plan suggests a planned diversification or liquidity event rather than a reaction to adverse non-public information.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and transparent divestment strategy rather than an immediate reaction to new, undisclosed information.

Negatives

• Insider selling, even when pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake in the company.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by investors for signals about management's confidence in the company's future prospects. While a 10b5-1 plan mitigates the immediate negative interpretation, the animal health industry is subject to various factors, including commodity prices, disease outbreaks, and regulatory changes, which can influence company performance and insider trading decisions.

Related Party Transactions

• Sales of Class A Common Stock by BFI Co., LLC, over which Jack Bendheim (President and CEO, Director, 10% Owner) exercises voting and dispositive power.

Stakeholder Impact

• Shareholders: May interpret the insider sales as a slight reduction in management's direct equity alignment, though the 10b5-1 plan context provides transparency.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific transaction report.

Key Dates

Keywords

Insider trading, Form 4, PHIBRO ANIMAL HEALTH CORP, PAHC, Jack Bendheim, 10b5-1 plan, stock sale, beneficial ownership, CEO, director, 10% owner